We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Topical Antibiotics and Intravitreous Injections

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00410891
First Posted: December 13, 2006
Last Update Posted: November 6, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Christopher Ta, Stanford University
October 2, 2006
December 13, 2006
May 13, 2014
June 12, 2014
November 6, 2017
July 2008
December 2009   (Final data collection date for primary outcome measure)
Positive Culture [ Time Frame: Study day 1, assessed following administration of study treatment ]
The percentage of patients with a positive bacterial culture following administration of study treatment is presented.
Not Provided
Complete list of historical versions of study NCT00410891 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Topical Antibiotics and Intravitreous Injections
Not Provided
Evaluation of efficacy of topical preoperative antibiotics in patients undergoing intravitreous injections.
Not Provided
Interventional
Phase 4
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
  • Intravitreous
  • Injections
Drug: gatifloxacin
Experimental: topical antibiotic
topical gatifloxacin 4 times per day
Intervention: Drug: gatifloxacin
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
129
December 2009
December 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • intravitreous injection

Exclusion Criteria:

  • antibiotic use
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00410891
96803 (eProtocol 4384)
Not Provided
Not Provided
Not Provided
Christopher Ta, Stanford University
Stanford University
Not Provided
Principal Investigator: Christopher Ta, MD Stanford University
Stanford University
October 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP